Products

From data to decision,
in a single step.

Great data is the starting point, not the destination. Our products are built to close the distance between a question and a confident answer — ask the way you'd ask a colleague, and get a sourced response in seconds.

Full policy
Not a summary

Pharmacy and medical alike — with the downstream criteria and restrictions behind each.

Daily
Always current

Automated capture, not a monthly manual research cycle.

Every point
Traceable to source

We can show you the exact section of the source document it came from.

Inside the platform

Any decision, one click away.

Market intelligence built for the decisions you actually have to make — coverage, restrictions, payer dynamics, and the sourced answer behind each, ready to act on.

Market Overview

Market distribution at a glance

Channel, plan-type, and region-level distribution of covered lives — the opening view that tells your team where the market actually sits before they drill in.

→Geographic footprint down to the state level
→Covered lives by channel — commercial, Medicare, Medicaid
→Top corporate parents ranked by enrollment
Covered lives by channel
Commercial
Medicare
Medicaid
PBM
National State County
Drug coverage

Every benefit design, side by side

Coverage status by drug across medical, pharmacy, and dual benefit — with tier, restriction depth, and last-updated dates on every row, no toggling between systems.

→Medical, pharmacy, and dual benefit, cross-linked in one view
→Automated daily refresh, so the record is always current
→Alerts on new drugs, tier moves, and restriction changes
Coverage by plan Rx · Medical
Preferred Covered Restricted
Payer intelligence

Sourced, real-time policy criteria

The actual policy criteria behind a decision — sourced, dated, and traceable back to the payer document it came from. Plus the lives, relationships, and events behind every payer.

→National & subnational lives by payer and plan type
→Payer–PBM–employer ownership and carve-outs
→Contract wins, formulary actions, and market events
Policy criteria
Step therapy required: documented trial and failure of two preferred agents.
Source payer policy · § 4.2 · dated
Medical intelligence

Medical, pharmacy, and dual benefit

Three benefit designs, captured at equal depth — medical, pharmacy, and dual-benefit drugs covered under both. Site-of-care, J-code reimbursement, and the downstream criteria behind each.

→Medical benefit — site-of-care, buy-and-bill, J-code detail
→Pharmacy benefit — formulary, tier, and restriction depth
→Dual benefit — drugs covered under both, reconciled in one record
Three benefit designs
Medical
Pharmacy
Dual
reconciled
One drug. One coverage picture.
ChatAgent

Ask the platform anything

The conversational layer over everything above — AI trained on decades of our own market access expertise. Questions in, instant sourced answers out.

→Ask the way you'd ask a colleague — get a sourced answer
→Competitive comparisons and access strategy on demand
→Executive summaries generated from live data
Ask · answer live
answered from live data · traceable to source
Who uses it

One platform. One set of numbers. No version conflicts.

Manufacturer teams, the C-suite, consultants, and investors measuring the market all work from the same dataset — so the number in a field conversation matches the number in the board deck.

Market access

Know where access breaks

Restriction depth by payer and indication, and the policy criteria driving it.

Field & account teams

Walk in prepared

Accounts, profiles, and coverage by drug — the same numbers ops and marketing see.

Analytics & ops

Skip the reconciliation

Recurring delivery on your cadence, mastered to one taxonomy, straight into your warehouse.

Leadership & C-suite

Answer in the meeting

Ask the ChatAgent and get a sourced answer while the question is still on the table.

Consultants & advisors

Defend the recommendation

Cite the source policy behind every finding you put in front of a client.

Investors & analysts

Measure the market

Track access position and coverage shifts across manufacturers and therapeutic areas.

See it on your own portfolio.

Book a live walkthrough and watch BatterUp answer real questions about your brands.

Book a walkthrough →